<n-docbody><doc bill="Y"><content.metadata.block><cmd.identifiers><cmd.cites><cmd.second.line.cite><bop/><bos/>Multidistrict Lit Man § 7:15<eos/><eop/></cmd.second.line.cite></cmd.cites></cmd.identifiers></content.metadata.block><prop.block><prop.head toc-guid=""><bop/><bos/><headtext>Multidistrict Litigation Manual</headtext><eos/><eop/></prop.head><content.metadata.block><cmd.dates><cmd.currency.default iso.d="20190501"><bop/><bos/>May 2019 Update<eos/><eop/></cmd.currency.default></cmd.dates></content.metadata.block><author.line><bop/><bos/><author>David F. Herr[<footnote.reference refid="If5d4a9116b3e11e99b03e53d6dd36aa2">a0</footnote.reference>]</author><eos/><eop/></author.line><prop.head toc-guid="I97b7f560933b11da99e2b07024dacc26"><bop/><bos/><label.name>Part</label.name><label.designator>I.</label.designator><headtext>Handling Cases Before the Judicial Panel on Multidistrict Litigation</headtext><eos/><eop/></prop.head><prop.head toc-guid="I358217d0933c11da99e2b07024dacc26"><bop/><bos/><label.name>Chapter</label.name><label.designator>7.</label.designator><headtext>Selection of a Transferee Judge</headtext><eos/><eop/></prop.head></prop.block><message.block><include.copyright n-include_collection="w_wlnv_msg" n-include_guid="I1DA35ED81DD211B281BAD200220BDFCA">Copyright (c) 2017 Thomson/RIA All rights reserved.</include.copyright></message.block><section><section.front><doc.title toc-guid="I63036ce0542b11dfa2a4f8f98376a475"><head parent="doc.title"><bop/><bos/><label.name>§ </label.name><label.designator>7:15.</label.designator><headtext>MDL experience</headtext><eos/><eop/></head></doc.title></section.front><section.body><para><bop/><bos/><paratext>Experience handling an MDL docket is clearly a factor that the Panel considers in evaluating whether a particular judge is a likely candidate for handling a particular docket.[<eos/><bos/><footnote.reference refid="If5d4f7306b3e11e99b03e53d6dd36aa2">1</footnote.reference>] This factor is of greatest weight for a judge who is both experienced in handling a prior MDL docket, but is not currently assigned one.[<eos/><bos/><footnote.reference refid="If5d4f7316b3e11e99b03e53d6dd36aa2">2</footnote.reference>] This is consistent with the Panel&apos;s tendency to favor “spreading” MDL dockets to districts that aren&apos;t currently handling any MDL dockets. <eos/><bos/><ital>See</ital> <cite.query w-ref-type="NA" w-normalized-cite="MDLITMANs6:22" w-pub-number="185218" ID="If5d656c06b3e11e99b03e53d6dd36aa2">§ 6:22</cite.query>.<eos/></paratext><eop/></para><para><bop/><bos/><paratext>The Panel may just as well select a transferee judge specifically because he or she is currently handling a related MDL docket.[<eos/><bos/><footnote.reference refid="If5d656c16b3e11e99b03e53d6dd36aa2">3</footnote.reference>] The Panel&apos;s interest in assigning transferred litigation to a judge who has not presided over an MDL docket is more pronounced in recent years. <eos/><bos/>The Panel has noted that experience handling in a complex docket involving the same type of case as now under consideration is germane to its decision.[<eos/><bos/><footnote.reference refid="If5d656c26b3e11e99b03e53d6dd36aa2">4</footnote.reference>] Similarly, experience handling similar MDL litigation is something the Panel has noted as favoring a particular transferee judge.[<eos/><bos/><footnote.reference refid="If5d656c36b3e11e99b03e53d6dd36aa2">5</footnote.reference>] Experience handling a related, but concluded MDL docket.[<eos/><bos/><footnote.reference refid="If5d656c46b3e11e99b03e53d6dd36aa2">6</footnote.reference>] As important as experience with the transferee judge role is, the Panel in recent years has demonstrated a clear practice of spreading MDL assignments around. <eos/><bos/>One upshot of this is the Panel&apos;s tendency to centralize dockets before a judge who is experienced but who is not currently handling any cases as a transferee judge.[<eos/><bos/><footnote.reference refid="If5d656c56b3e11e99b03e53d6dd36aa2">7</footnote.reference>]</paratext><eos/><eop/></para><para><bop/><bos/><paratext>The Panel has also specifically noted that it was selecting a judge who had no prior experience as an MDL transferee judge.[<eos/><bos/><footnote.reference refid="If5d67dd06b3e11e99b03e53d6dd36aa2">8</footnote.reference>] A judge who has not “recently” received an MDL assignment may similarly be chosen by the Panel.[<eos/><bos/><footnote.reference refid="If5d67dd16b3e11e99b03e53d6dd36aa2">9</footnote.reference>] Without referencing MDL experience, the Panel occasionally may select a judge because of his or her experience handling complex litigation as a lawyer.[<eos/><bos/><footnote.reference refid="If5d67dd26b3e11e99b03e53d6dd36aa2">10</footnote.reference>] These cases illustrate the very pragmatic approach the panel takes to selection of a transferee judge. <eos/><bos/>In a recent decision involving an exceptionally complex docket involving hundreds of cases representing claims of millions of potential claimants, foreign discovery issues, numerous different product models and brands, and involvement of multiple governmental entities, the Panel selected a judge who had handled nine earlier MDL dockets.[<eos/><bos/><footnote.reference refid="If5d67dd36b3e11e99b03e53d6dd36aa2">11</footnote.reference>]</paratext><eos/><eop/></para></section.body></section><author.footnotes><footnote ID="If5d4a9116b3e11e99b03e53d6dd36aa2"><label.designator>a0</label.designator><footnote.body><para><bop/><bos/><paratext>Maslon Edelman Borman &amp; Brand, LLP, Minneapolis, Minnesota.<eos/></paratext><eop/></para></footnote.body></footnote></author.footnotes><footnote.block><footnote ID="If5d4f7306b3e11e99b03e53d6dd36aa2"><label.designator>1</label.designator><footnote.body><para><bop/><bos/><paratext><cite.query w-src-number="0352637343" w-serial-number="2038641949" w-seq-number="00001" w-ref-type="RP" w-pub-number="0007903" ID="I659886f16b3e11e984eaf7fbfa3d7525">In re Viagara (Sildenafil Citrate) Products Liability Litigation, 176 F. Supp. 3d 1377 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2037790661" w-seq-number="00002" w-ref-type="RP" w-pub-number="0007903" ID="I659886f36b3e11e984eaf7fbfa3d7525">In re Bair Hugger Forced Air Warming Devices Products Liability Litigation, 148 F. Supp. 3d 1383 (J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2037790571" w-seq-number="00003" w-ref-type="RP" w-pub-number="0007903" ID="I659886f56b3e11e984eaf7fbfa3d7525">In re Medical Informatics Engineering, Inc., Customer Data Security Breach Litigation, 148 F. Supp. 3d 1381 (U.S.J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2036884713" w-seq-number="00004" w-ref-type="RP" w-pub-number="0007903" ID="I659886f76b3e11e984eaf7fbfa3d7525">In re Pacquiao-Mayweather Boxing Match Pay-Per-View Litigation, 122 F. Supp. 3d 1372 (J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2036449342" w-seq-number="00005" w-ref-type="RP" w-pub-number="0007903" ID="I659886f96b3e11e984eaf7fbfa3d7525">In re Alibaba Group Holding Limited Securities Litigation, 109 F. Supp. 3d 1379 (J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2036442383" w-seq-number="00006" w-ref-type="RP" w-pub-number="0007903" ID="I659886fb6b3e11e984eaf7fbfa3d7525">In re Walgreens Herbal Supplements Marketing and Sales Practices Litigation, 109 F. Supp. 3d 1373 (J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2036449454" w-seq-number="00007" w-ref-type="RP" w-pub-number="0007903" ID="I659886fd6b3e11e984eaf7fbfa3d7525">In re Disposable Contact Lens Antitrust Litigation, 109 F. Supp. 3d 1369 (U.S.J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2036449446" w-seq-number="00008" w-ref-type="RP" w-pub-number="0007903" ID="I659886ff6b3e11e984eaf7fbfa3d7525">In re Anthem, Inc. Customer Data Security Breach Litigation, 109 F. Supp. 3d 1364 (J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2032773135" w-seq-number="00009" w-ref-type="RP" w-pub-number="0004637" ID="I659887016b3e11e984eaf7fbfa3d7525">In re Amazon.com, Inc., Fulfillment Center Fair Labor Standards Act (FLSA) and Wage and Hour Litigation, 999 F. Supp. 2d 1375 (J.P.M.L. 2014)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2032781636" w-seq-number="00010" w-ref-type="RP" w-pub-number="0004637" ID="I659887036b3e11e984eaf7fbfa3d7525">In re Collecto, Inc., Telephone Consumer Protection Act (TCPA) Litigation, 999 F. Supp. 2d 1373 (J.P.M.L. 2014)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2032413341" w-seq-number="00011" w-ref-type="RP" w-pub-number="0004637" ID="I659887056b3e11e984eaf7fbfa3d7525">In re Nutramax Cosamin Marketing and Sales Practices Litigation, 988 F. Supp. 2d 1371 (J.P.M.L. 2013)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2031813067" w-seq-number="00012" w-ref-type="RP" w-pub-number="0004637" ID="I659887076b3e11e984eaf7fbfa3d7525">In re Monsanto Co. Genetically-Engineered Wheat Litigation, 978 F. Supp. 2d 1373 (J.P.M.L. 2013)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2023517469" w-seq-number="00013" w-ref-type="RP" w-pub-number="0004637" ID="I659887096b3e11e984eaf7fbfa3d7525">In re Bank of America Home Affordable Modification Program (HAMP) Contract Litigation, 746 F. Supp. 2d 1359 (J.P.M.L. 2010)</cite.query> (Panel notes “wealth of prior MDL experience” of transferee judge.); <eos/><bos/><cite.query w-src-number="0352637343" w-serial-number="2016771277" w-seq-number="00014" w-ref-type="RP" w-pub-number="0004637" ID="I6598870b6b3e11e984eaf7fbfa3d7525">In re Puerto Rican Cabotage Antitrust Litigation, 571 F. Supp. 2d 1378 (J.P.M.L. 2008)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2016771276" w-seq-number="00015" w-ref-type="RP" w-pub-number="0004637" ID="I6598870d6b3e11e984eaf7fbfa3d7525">In re Digitek Products Liability Litigation, 571 F. Supp. 2d 1376 (J.P.M.L. 2008)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2015730625" w-seq-number="00016" w-ref-type="RP" w-pub-number="0004637" ID="I6598870f6b3e11e984eaf7fbfa3d7525">In re Texas Roadhouse Fair and Accurate Credit Transactions Act (FACTA) Litigation, 542 F. Supp. 2d 1370 (J.P.M.L. 2008)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2011233716" w-seq-number="00017" w-ref-type="RP" w-pub-number="0004637" ID="I659887116b3e11e984eaf7fbfa3d7525">In re Merscorp Inc., Real Estate Settlement Procedures Act (RESPA) Litigation, 473 F. Supp. 2d 1379 (J.P.M.L. 2007)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2010560083" w-seq-number="00018" w-ref-type="RP" w-pub-number="0004637" ID="I659887136b3e11e984eaf7fbfa3d7525">In re Intern. Air Transp. Surcharge Antitrust Litigation, 460 F. Supp. 2d 1377 (J.P.M.L. 2006)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2008553259" w-seq-number="00019" w-ref-type="RP" w-pub-number="0004637" ID="I659887156b3e11e984eaf7fbfa3d7525">In re Celexa and Lexapro Products Liability Litigation, 416 F. Supp. 2d 1361 (J.P.M.L. 2006)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2008553257" w-seq-number="00020" w-ref-type="RP" w-pub-number="0004637" ID="I659887176b3e11e984eaf7fbfa3d7525">In re Vitamin C Antitrust Litigation, 416 F. Supp. 2d 1352 (J.P.M.L. 2006)</cite.query> (available judge with MDL experience); <cite.query w-src-number="0352637343" w-serial-number="2008318693" w-seq-number="00021" w-ref-type="RP" w-pub-number="0004637" ID="I659887196b3e11e984eaf7fbfa3d7525">In re Viagra Products Liability Litigation, 414 F. Supp. 2d 1357 (J.P.M.L. 2006)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2006243939" w-seq-number="00022" w-ref-type="RP" w-pub-number="0004637" ID="I6598871b6b3e11e984eaf7fbfa3d7525">In re Vioxx Products Liability Litigation, 360 F. Supp. 2d 1352 (J.P.M.L. 2005)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2002691943" w-seq-number="00023" w-ref-type="RP" w-pub-number="0004637" ID="I6598871d6b3e11e984eaf7fbfa3d7525">In re Commercial Money Center, Inc., Equipment Lease Litigation, 229 F. Supp. 2d 1379 (J.P.M.L. 2002)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If5d4f7316b3e11e99b03e53d6dd36aa2"><label.designator>2</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See, e.g.</ital>, <cite.query w-src-number="0352637343" w-serial-number="2020646613" w-seq-number="00024" w-ref-type="RP" w-pub-number="0004637" ID="I659a82c16b3e11e984eaf7fbfa3d7525">In re Apple iPhone 3G and 3GS MMS Marketing and Sales Practices Litigation, 657 F. Supp. 2d 1378 (J.P.M.L. 2009)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2020646167" w-seq-number="00025" w-ref-type="RP" w-pub-number="0004637" ID="I659a82c36b3e11e984eaf7fbfa3d7525">In re Pamidronate Products Liability Litigation, 657 F. Supp. 2d 1368 (J.P.M.L. 2009)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2019952801" w-seq-number="00026" w-ref-type="RP" w-pub-number="0004637" ID="I659a82c56b3e11e984eaf7fbfa3d7525">In re Yasmin, Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, 655 F. Supp. 2d 1343 (J.P.M.L. 2009)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2019793575" w-seq-number="00027" w-ref-type="RP" w-pub-number="0004637" ID="I659a82c76b3e11e984eaf7fbfa3d7525">In re Celexa and Lexapro Marketing and Sales Practices Litigation, 652 F. Supp. 2d 1377 (J.P.M.L. 2009)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2019793573" w-seq-number="00028" w-ref-type="RP" w-pub-number="0004637" ID="I659a82c96b3e11e984eaf7fbfa3d7525">In re WellPoint, Inc., Out-of-Network UCR Rates Litigation, 652 F. Supp. 2d 1375 (J.P.M.L. 2009)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2018630170" w-seq-number="00029" w-ref-type="RP" w-pub-number="0004637" ID="I659a82cb6b3e11e984eaf7fbfa3d7525">In re Bayer Corp. Combination Aspirin Products Marketing and Sales Practices Litigation, 609 F. Supp. 2d 1379 (J.P.M.L. 2009)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2018178961" w-seq-number="00030" w-ref-type="RP" w-pub-number="0004637" ID="I659a82cd6b3e11e984eaf7fbfa3d7525">In re Air Crash at Tegucigalpa, Honduras, on May 30, 2008, 598 F. Supp. 2d 1368 (J.P.M.L. 2009)</cite.query>. <eos/><bos/><ital>See also</ital> <cite.query w-src-number="0352637343" w-serial-number="2022791014" w-seq-number="00031" w-ref-type="RP" w-pub-number="0004637" ID="I659a82cf6b3e11e984eaf7fbfa3d7525">In re Brican America LLC Equipment Lease Litigation, 731 F. Supp. 2d 1358 (J.P.M.L. 2010)</cite.query> (experienced transferee judge with only one other MDL docket).<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If5d656c16b3e11e99b03e53d6dd36aa2"><label.designator>3</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See, e.g.</ital>, <cite.query w-src-number="0352637343" w-serial-number="2034595843" w-seq-number="00032" w-ref-type="RP" w-pub-number="0007903" ID="I659b94316b3e11e984eaf7fbfa3d7525">In re: London Silver Fixing, Ltd., Antitrust Litigation, 52 F. Supp. 3d 1381 (U.S.J.P.M.L. 2014)</cite.query> (notes as selection factor, but points out Panel is not suggest what degree of coordination ought to take place); <cite.query w-src-number="0352637343" w-serial-number="2019643736" w-seq-number="00033" w-ref-type="RP" w-pub-number="0004637" ID="I659b94336b3e11e984eaf7fbfa3d7525">In re Meridian Funds Group Securities &amp; Employee Retirement Income Security Act (ERISA) Litigation, 645 F. Supp. 2d 1360 (U.S.J.P.M.L. 2009)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2012966911" w-seq-number="00034" w-ref-type="RP" w-pub-number="0004637" ID="I659b94356b3e11e984eaf7fbfa3d7525">In re Vonage Marketing and Sales Practices, 505 F. Supp. 2d 1375 (J.P.M.L. 2007)</cite.query> (judge handling MDL docket against same common defendant).<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If5d656c26b3e11e99b03e53d6dd36aa2"><label.designator>4</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See, e.g.</ital>, <cite.query w-src-number="0352637343" w-serial-number="2036449454" w-seq-number="00035" w-ref-type="RP" w-pub-number="0007903" ID="I659c57816b3e11e984eaf7fbfa3d7525">In re Disposable Contact Lens Antitrust Litigation, 109 F. Supp. 3d 1369 (J.P.M.L. 2015)</cite.query> (experience with cases involving anticompetitive conduct in same industry); <cite.query w-src-number="0352637343" w-serial-number="2006243939" w-seq-number="00036" w-ref-type="RP" w-pub-number="0004637" ID="I659c57836b3e11e984eaf7fbfa3d7525">In re Vioxx Products Liability Litigation, 360 F. Supp. 2d 1352 (J.P.M.L. 2005)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If5d656c36b3e11e99b03e53d6dd36aa2"><label.designator>5</label.designator><footnote.body><para><bop/><bos/><paratext><cite.query w-src-number="0352637343" w-serial-number="2007565831" w-seq-number="00037" w-ref-type="RP" w-pub-number="0004637" ID="I659cccb16b3e11e984eaf7fbfa3d7525">In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation, 398 F. Supp. 2d 1356 (J.P.M.L. 2005)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If5d656c46b3e11e99b03e53d6dd36aa2"><label.designator>6</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See, e.g.,</ital> <cite.query w-src-number="0352637343" w-serial-number="2016316621" w-seq-number="00038" w-ref-type="RP" w-pub-number="0004637" ID="I659db7116b3e11e984eaf7fbfa3d7525">In re Flat Glass Antitrust Litigation (No. II), 559 F. Supp. 2d 1407 (J.P.M.L. 2008)</cite.query> (transfer to judge who had handled <begin.quote ID="QT_0001"/>“<cite.query w-src-number="0352637343" w-serial-number="2016316621" w-seq-number="00039" w-ref-type="RS" w-pub-number="0004637" ID="I659db7136b3e11e984eaf7fbfa3d7525">In re Flat Glass Antitrust Litigation”<end.quote refid="QT_0001"/>);</cite.query> <cite.query w-src-number="0352637343" w-serial-number="2007565831" w-seq-number="00040" w-ref-type="RP" w-pub-number="0004637" ID="I659db7156b3e11e984eaf7fbfa3d7525">In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation, 398 F. Supp. 2d 1356 (J.P.M.L. 2005)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If5d656c56b3e11e99b03e53d6dd36aa2"><label.designator>7</label.designator><footnote.body><para><bop/><bos/><paratext>See, e.g., <cite.query w-src-number="0352637343" w-serial-number="2033539090" w-seq-number="00041" w-ref-type="RP" w-pub-number="0007903" ID="I659ea1716b3e11e984eaf7fbfa3d7525">In re Yosemite Nat. Park Hantavirus Litigation, 24 F. Supp. 3d 1370 (J.P.M.L. 2014)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2031813066" w-seq-number="00042" w-ref-type="RP" w-pub-number="0004637" ID="I659ea1736b3e11e984eaf7fbfa3d7525">In re Vehicle Carrier Services Antitrust Litigation, 978 F. Supp. 2d 1382 (J.P.M.L. 2013)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2024536987" w-seq-number="00043" w-ref-type="RP" w-pub-number="0004637" ID="I659ea1756b3e11e984eaf7fbfa3d7525">In re Prudential Ins. Co. of America SGLI/VGLI Contract Litigation, 763 F. Supp. 2d 1374 (U.S.J.P.M.L. 2011)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2020646167" w-seq-number="00044" w-ref-type="RP" w-pub-number="0004637" ID="I659ea1776b3e11e984eaf7fbfa3d7525">In re: Pamidronate Products Liability Litigation, 657 F. Supp. 2d 1368 (U.S.J.P.M.L. 2009)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2019952801" w-seq-number="00045" w-ref-type="RP" w-pub-number="0004637" ID="I659ea1796b3e11e984eaf7fbfa3d7525">In re: Yasmin, Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, 655 F. Supp. 2d 1343 (U.S.J.P.M.L. 2009)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2018630170" w-seq-number="00046" w-ref-type="RP" w-pub-number="0004637" ID="I659ea17b6b3e11e984eaf7fbfa3d7525">In re: Bayer Corp. Combination Aspirin Products Marketing and Sales Practices Litigation, 609 F. Supp. 2d 1379 (U.S.J.P.M.L. 2009)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2018178961" w-seq-number="00047" w-ref-type="RP" w-pub-number="0004637" ID="I659ea17d6b3e11e984eaf7fbfa3d7525">In Re Air Crash at Tegucigalpa, Honduras, on May 30, 2008, 598 F. Supp. 2d 1368 (U.S.J.P.M.L. 2009)</cite.query> (Panel also notes judge has favorable overall caseload).<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If5d67dd06b3e11e99b03e53d6dd36aa2"><label.designator>8</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See</ital> <cite.query w-src-number="0352637343" w-serial-number="2041792543" w-seq-number="00048" w-ref-type="RP" w-pub-number="0007903" ID="I65a028116b3e11e984eaf7fbfa3d7525">In re FieldTurf Artificial Turf Marketing and Sales Practices Litigation, 254 F. Supp. 3d 1379 (U.S.J.P.M.L. 2017)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2039935936" w-seq-number="00049" w-ref-type="RP" w-pub-number="0007903" ID="I65a028136b3e11e984eaf7fbfa3d7525">In re Abilify (Aripiprazole) Products Liability Litigation, 232 F. Supp. 3d 1342 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2040526745" w-seq-number="00050" w-ref-type="RP" w-pub-number="0007903" ID="I65a028156b3e11e984eaf7fbfa3d7525">In re Atrium Medical Corp. C-Qur Mesh Products Liability Litigation, 223 F. Supp. 3d 1355 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2040526741" w-seq-number="00051" w-ref-type="RP" w-pub-number="0007903" ID="I65a028176b3e11e984eaf7fbfa3d7525">In re Invokana (Canagliflozin) Products Liability Litigation, 223 F. Supp. 3d 1345 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2039510480" w-seq-number="00052" w-ref-type="RP" w-pub-number="0007903" ID="I65a028196b3e11e984eaf7fbfa3d7525">In re The Honest Company, Inc. , Sodium Lauryl Sulfate (SLS) Marketing and Sales Practices Litigation, 222 F. Supp. 3d 1349 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2039935897" w-seq-number="00053" w-ref-type="RP" w-pub-number="0007903" ID="I65a0281b6b3e11e984eaf7fbfa3d7525">In re Taxotere (Docetaxel) Products Liability Litigation, 220 F. Supp. 3d 1360 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2039935912" w-seq-number="00054" w-ref-type="RP" w-pub-number="0007903" ID="I65a0281d6b3e11e984eaf7fbfa3d7525">In re 21st Century Oncology Customer Data Security Breach Litigation, 214 F. Supp. 3d 1357 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2039935888" w-seq-number="00055" w-ref-type="RP" w-pub-number="0007903" ID="I65a0281f6b3e11e984eaf7fbfa3d7525">In re: Roundup Products Liability Litigation, 214 F. Supp. 3d 1346 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2038992589" w-seq-number="00056" w-ref-type="RP" w-pub-number="0007903" ID="I65a028216b3e11e984eaf7fbfa3d7525">In re Interest Rate Swaps Antitrust Litigation, 190 F. Supp. 3d 1364 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2038992581" w-seq-number="00057" w-ref-type="RP" w-pub-number="0007903" ID="I65a028236b3e11e984eaf7fbfa3d7525">In re Air Crash over the Southern Indian Ocean, on March 8, 2014, 190 F. Supp. 3d 1358 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2038650536" w-seq-number="00058" w-ref-type="RP" w-pub-number="0007903" ID="I65a028256b3e11e984eaf7fbfa3d7525">In re Santa Fe Natural Tobacco Company Marketing and Sales Practices Litigation, 178 F. Supp. 3d 1377 (J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2038641650" w-seq-number="00059" w-ref-type="RP" w-pub-number="0007903" ID="I65a028276b3e11e984eaf7fbfa3d7525">In re Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation, 178 F. Supp. 3d 1374 (J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2038641643" w-seq-number="00060" w-ref-type="RP" w-pub-number="0007903" ID="I65a028296b3e11e984eaf7fbfa3d7525">In re Vizio, Inc., Consumer Privacy Litigation, 176 F. Supp. 3d 1374 (U.S.J.P.M.L. 2016)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2037398381" w-seq-number="00061" w-ref-type="RP" w-pub-number="0007903" ID="I65a0282b6b3e11e984eaf7fbfa3d7525">In re Domestic Airline Travel Antitrust Litigation, 140 F. Supp. 3d 1344 (J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2035757729" w-seq-number="00062" w-ref-type="RP" w-pub-number="0007903" ID="I65a0282d6b3e11e984eaf7fbfa3d7525">In re: TD Bank, N.A., Debit Card Overdraft Fee Litigation, 96 F. Supp. 3d 1378 (U.S.J.P.M.L. 2015)</cite.query>; <cite.query w-src-number="0352637343" w-serial-number="2033577422" w-seq-number="00063" w-ref-type="RP" w-pub-number="0007903" ID="I65a0282f6b3e11e984eaf7fbfa3d7525">In re: TLI Communications LLC Patent Litigation, 26 F. Supp. 3d 1396 (U.S.J.P.M.L. 2014)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If5d67dd16b3e11e99b03e53d6dd36aa2"><label.designator>9</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See, e.g.,</ital> <cite.query w-src-number="0352637343" w-serial-number="2021361335" w-seq-number="00064" w-ref-type="RP" w-pub-number="0004637" ID="I65a139816b3e11e984eaf7fbfa3d7525">In re: Air Crash at Madrid, Spain, on August 20, 2008, 672 F. Supp. 2d 1378 (U.S.J.P.M.L. 2010)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If5d67dd26b3e11e99b03e53d6dd36aa2"><label.designator>10</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See</ital> <cite.query w-src-number="0352637343" w-serial-number="2021734289" w-seq-number="00065" w-ref-type="RP" w-pub-number="0004637" ID="I65a1aeb16b3e11e984eaf7fbfa3d7525">In re: Toyota Motor Corp. Unintended Acceleration Marketing, Sales Practices, Products Liability Litigation, 704 F. Supp. 2d 1379 (U.S.J.P.M.L. 2010)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote><footnote ID="If5d67dd36b3e11e99b03e53d6dd36aa2"><label.designator>11</label.designator><footnote.body><para><bop/><bos/><paratext><ital>See</ital> <cite.query w-src-number="0352637343" w-serial-number="2037790745" w-seq-number="00066" w-ref-type="RP" w-pub-number="0000999" ID="I65a24af16b3e11e984eaf7fbfa3d7525">In re Volkswagen “Clean Diesel” Marketing, Sales Practices, and Products Liability Litigation, 2015 WL 8543102 (U.S.J.P.M.L. 2015)</cite.query>.<eos/></paratext><eop/></para></footnote.body></footnote></footnote.block><content.metadata.block><cmd.royalty><cmd.copyright><bop/><bos/>Westlaw. © 2019 Thomson Reuters.  <eos/><bos/>No Claim to Orig. U.S. Govt. <eos/><bos/>Works.<eos/><eop/></cmd.copyright></cmd.royalty><cmd.identifiers><cmd.cites><cmd.first.line.cite><bop/><bos/>MDLITMAN § 7:15<eos/><eop/></cmd.first.line.cite></cmd.cites></cmd.identifiers></content.metadata.block></doc></n-docbody>
